Publications by authors named "Ioannis Mavromatis"

A dataset of body tracking information is presented. The dataset consists of 315 captured walking sequences. Each sequence is simultaneously captured by two Azure Kinect devices.

View Article and Find Full Text PDF

A dataset of sensor measurements is presented. Our dataset contains discrete measurements of 8 IoT devices located in various places in a research lab at the University of Bristol. Nordic nRF52840 DK IoT devices periodically collects environmental data, such as temperature, humidity, pressure, gas, room light intensity, accelerometer; including also a measurement quality indicator.

View Article and Find Full Text PDF

A dataset of street light images is presented. Our dataset consists of ∼350 k images, taken from 140 UMBRELLA nodes installed in the South Gloucestershire region in the UK. Each UMBRELLA node is installed on the pole of a lamppost and is equipped with a Raspberry Pi Camera Module v1 facing upwards towards the sky and lamppost light bulb.

View Article and Find Full Text PDF

A dataset of measurements of ETSI ITS-G5 Dedicated Short Range Communications (DSRC) is presented. Our dataset consists of network interactions happening between two On-Board Units (OBUs) and four Road Side Units (RSUs). Each OBU was fitted onto a vehicle driven across the FLOURISH Test Track in Bristol, UK.

View Article and Find Full Text PDF

Parkinson's disease is a neurodegenerative disease, with a constantly increasing prevalence and a high global financial impact arising from direct and indirect costs. Large-scale, observational studies provide data that support the better comprehension of disease aspects, constitute a baseline reference for future studies and assist comparisons among different patient populations, allowing the recognition of distinctive characteristics and special needs. The present study is the first to depict the clinical characteristics and their interplay in a large sample of Parkinson's disease (PD) patients in Greece.

View Article and Find Full Text PDF

Background: In response to the ongoing debate on the long-term effects of assisted reproduction technologies, such as IVF, we systematically reviewed and meta-analyzed available evidence on the association between controlled ovarian hyperstimulation for IVF and risk of ovarian, endometrial and cervical cancer.

Methods: Eligible studies were identified and pooled effect estimates for relative risk (RR) were calculated by cancer type among two reference groups (general population or infertile women), through fixed- or random-effects models as appropriate.

Results: Nine cohort studies were synthesized, corresponding to a total size of 109 969 women exposed to IVF, among whom 76 incident cases of ovarian, 18 of endometrial and 207 cases of cervical cancer were studied.

View Article and Find Full Text PDF

Objective: The current recommended endometrial cancer surgical treatment is abdominal extrafascial total hysterectomy with bilateral salpingo-oophorectomy followed by pelvic lymphadenectomy if >50% myometrial invasion is estimated by intraoperative gross examination (IGE). This meta-analysis aims to quantify evidence regarding the validity/predictive value of IGE staging compared with final histology.

Design: Meta-analysis of studies published until October 2011.

View Article and Find Full Text PDF

Background And Purpose: Experimental autoimmune encephalomyelitis (EAE) is a widely used model of multiple sclerosis (MS) and both conditions have been reported to exhibit reduced endocannabinoid activity. The purpose of this study was to address the effect of exogenously administered 2-arachidonoylglycerol (2AG), an endocannabinoid receptor ligand, on acute phase and chronic disability in EAE.

Experimental Approach: Acute and chronic EAE models were induced in susceptible mice and 2AG-treatment was applied for 14 days from day of disease induction.

View Article and Find Full Text PDF
Article Synopsis
  • Experimental allergic encephalomyelitis (EAE) serves as a key animal model for studying multiple sclerosis (MS), helping researchers understand the disease's inflammatory attacks on the central nervous system and myelin sheath.
  • Insights gained from EAE studies have identified various myelin antigens targeted by the immune system and have informed the use of immunomodulating therapies for MS.
  • While altered peptide ligands (APL) show promise in treating EAE and potentially MS, challenges like peptide sensitivity to enzymes and side effects exist, necessitating further research and clinical trials to assess their effectiveness.
View Article and Find Full Text PDF